VETERINARY PLASMA-LYTE A- sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride injection, s

国家: 美国

语言: 英文

来源: NLM (National Library of Medicine)

有效成分:

SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37), SODIUM GLUCONATE (UNII: R6Q3791S76) (GLUCONIC ACID - UNII:R4R8J0Q44B, SODIUM CATION - UNII:LYR4M0NH37), SODIUM ACETATE (UNII: 4550K0SC9B) (ACETATE ION - UNII:569DQM74SC, SODIUM CATION - UNII:LYR4M0NH37), POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152, CHLORIDE ION - UNII:Q32ZN48698), MAGNESIUM CHLORIDE (UNII: 02F3473H9O) (MAGNESIUM CATION - UNII:T6V3LHY838, CHLORIDE ION - UNI

可用日期:

Baxter Healthcare Corporation

给药途径:

INTRAVENOUS

处方类型:

PRESCRIPTION

疗效迹象:

PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is indicated as a source of water and electrolytes or as an alkalinizing agent. PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is compatible with blood or blood components. It may be administered prior to or following the infusion of blood through the same administration set (i.e., as a priming solution), added to or infused concurrently with blood components, or used as a diluent in the transfusion of packed erythrocytes. PLASMA-LYTE A Injection and 0.9% Sodium Chloride Injection, USP are equally compatible with blood or blood components. None known

授权状态:

unapproved drug other

产品特点

VETERINARY PLASMA-LYTE A- SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM
ACETATE,
POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE INJECTION, SOLUTION
BAXTER HEALTHCARE CORPORATION
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
VETERINARY PLASMA-LYTE A
DESCRIPTION
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type
1, USP) is a sterile,
nonpyrogenic isotonic solution in a single dose container for
intravenous administration. It contains no
antimicrobial agents. Discard unused portion. The pH is adjusted with
sodium hydroxide. Composition,
osmolarity, pH, ionic concentration and caloric content are shown in
Table 1.
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type
1, USP) administered
intravenously has value as a source of water,
electrolytes, and calories. Normal physiologic osmolarity range is 280
to 310 mOsmol/L.
Administration of substantially hypertonic solutions may cause vein
damage.
The plastic container is fabricated from a specially formulated
polyvinyl chloride. The amount of water
that can permeate from inside the container into the overwrap is
insufficient to affect the solution
significantly.
Solutions in contact with the plastic container can leach out certain
of its chemical components in very
small amounts within the expiration period, e.g., di-2-ethylhexyl
phthalate (DEHP), up to 5 parts per
million. However, the safety of the plastic has been confirmed in
tests in animals according to USP
biological tests for plastic containers as well as by tissue culture
toxicity studies.
CLINICAL PHARMACOLOGY
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type
1, USP) has value as a
source of water and electrolytes. It is capable of inducing diuresis
depending on the clinical condition
of the patient.
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type
1, USP) produces a
metabolic alkalinizing effect. A